These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28000339)

  • 41. Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort study.
    Boswell L; Serés-Noriega T; Mesa A; Perea V; Pané A; Viñals C; Blanco J; Giménez M; Vinagre I; Esmatjes E; Conget I; Amor AJ
    Acta Diabetol; 2022 Dec; 59(12):1563-1574. PubMed ID: 36006487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
    Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
    BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Fernández-SanMartín M; Goday-Arno A
    Clin Exp Hypertens; 2017; 39(5):441-447. PubMed ID: 28590147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of cardiovascular secondary prevention guidelines in clinical practice: a nationwide survey in Italy.
    Perrone-Filardi P; Poli A; Ambrosio G; Proto C; Chimini C; Chiariello M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):149-53. PubMed ID: 20875948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.
    Ferrières J; Bérard E; Crisan O; Bongard V
    Arch Cardiovasc Dis; 2010 May; 103(5):302-9. PubMed ID: 20619240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clustering of hypertension, diabetes mellitus and dyslipidemia in a Nigerian population: a cross sectional study.
    Ogunleye OO; Ogundele SO; Akinyemi JO; Ogbera AO
    Afr J Med Med Sci; 2012 Jun; 41(2):191-5. PubMed ID: 23185918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients.
    Sánchez-Taínta A; Estruch R; Bulló M; Corella D; Gómez-Gracia E; Fiol M; Algorta J; Covas MI; Lapetra J; Zazpe I; Ruiz-Gutiérrez V; Ros E; Martínez-González MA;
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):589-93. PubMed ID: 18830087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utilisation of lipid-lowering therapies in outpatient settings in Poland: epidemiological survey Economedica Dyslipidaemia 2015.
    Szymański FM; Płatek AE; Ryś A; Semczuk-Kaczmarek K; Krzowski B; Wróbel K; Filipiak KJ
    Kardiol Pol; 2018; 76(3):648-654. PubMed ID: 29313565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attitudes and actions: A survey to assess statin use among Finnish patients with increased risk for cardiovascular events.
    Silvennoinen R; Turunen JH; Kovanen PT; Syvänne M; Tikkanen MJ
    J Clin Lipidol; 2017; 11(2):485-494. PubMed ID: 28502506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time-trends in prevalence and awareness of cardiovascular risk factors in an asymptomatic North Indian urban population.
    Bansal M; Shrivastava S; Mehrotra R; Agrawal V; Kasliwal RR
    J Assoc Physicians India; 2009 Aug; 57():568-73. PubMed ID: 20209717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin use and risk of epilepsy: a nested case-control study.
    Etminan M; Samii A; Brophy JM
    Neurology; 2010 Oct; 75(17):1496-500. PubMed ID: 20975051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
    Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
    Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
    BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perampanel in the general population and in people with intellectual disability: Differing responses.
    Shankar R; Henley W; Wehner T; Wiggans C; McLean B; Pace A; Mohan M; Sadler M; Doran Z; Hudson S; Allard J; Sander JW
    Seizure; 2017 Jul; 49():30-35. PubMed ID: 28552718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study].
    González-Juanatey JR; Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC
    Rev Esp Cardiol; 2011 Apr; 64(4):286-94. PubMed ID: 21411216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
    Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
    Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
    Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
    Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.